Mary‐Margaret Keating
-
- Chronic Lymphocytic Leukemia Research 14
- Hemoglobinopathies and Related Disorders 3
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments 11
- Acute Myeloid Leukemia Research 4
-
- Lymphoma Diagnosis and Treatment 11
-
- Viral-associated cancers and disorders 4
-
- Eosinophilic Disorders and Syndromes 3
-
- CNS Lymphoma Diagnosis and Treatment 2
- Co-authors
- David M. ByersHuansheng GongChris TuckerZ. B. JohnsonL. ReynoldsT. A. YazwinskiElihu H. EsteyRobert Delage
- Partner nations
- CanadaUnited StatesCzechia
In The Last Decade
Mary‐Margaret Keating
19 papers receiving 169 citations
Peers
Comparison fields: 5 of 58
- Genetics 74
- Hematology 72
- Pathology and Forensic Medicine 40
- Small Animals 16
- Animal Science and Zoology 18
Countries citing papers authored by Mary‐Margaret Keating
This map shows the geographic impact of Mary‐Margaret Keating's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary‐Margaret Keating with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary‐Margaret Keating more than expected).
Fields of papers citing papers by Mary‐Margaret Keating
This network shows the impact of papers produced by Mary‐Margaret Keating. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary‐Margaret Keating. The network helps show where Mary‐Margaret Keating may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary‐Margaret Keating, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 9 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 13 | |
| 12 | 2023 | 0 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 4 | |
| 15 | 2020 | 3 | |
| 16 | 2019 | 1 | |
| 17 | 2018 | 24 | |
| 18 | 2016 | 0 | |
| 19 | 2002 | 19 | |
| 20 | Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study. | 1997 | 25 |
About Mary‐Margaret Keating
Mary‐Margaret Keating is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 28 papers that have together received 181 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (11 papers), Lymphoma Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (4 papers), Viral-associated cancers and disorders (4 papers), Eosinophilic Disorders and Syndromes (3 papers), Hemoglobinopathies and Related Disorders (3 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (74 citations), Hematology (72 citations) and Pathology and Forensic Medicine (40 citations). Mary‐Margaret Keating has collaborated with scholars based in Canada, United States and Czechia. Frequent co-authors include David M. Byers, Huansheng Gong, Chris Tucker, Z. B. Johnson, L. Reynolds, T. A. Yazwinski, Elihu H. Estey, Robert Delage, Maria Grazia Zurlo and Sima Jeha. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.